The Ontario healthcare system is under strain, still recovering from the demands of the COVID-19 pandemic. The University Health Network (UHN) and Boehringer Ingelheim (Canada) Ltd. have partnered to address a critical need of heart failure patients.
The objective of the partnership is to expand patient reach of UHN’s successful Medly Program— an innovative, digital therapeutic solution that delivers the benefits of specialized clinical heart failure management at home while improving quality of life and reducing hospitalizations.
TRANSFORM HF co-lead Dr. Heather Ross (Head, Division of Cardiology UHN-SHS) led a team to Moosonee and Moose Factory in May to continue to deepen our partnership with Weeneebayko Area Health Authority.
Following a COVID-imposed hiatus, the collaboration to address heart failure in the Weeneebayko region was renewed with a visit consisting of in-person clinics, community outreach, and a sharing circle.
TRANSFORM HF will build, support and fund a deep community of multidisciplinary engineers, basic and data scientists, clinicians, and health experts whose innovative solutions will help monitor and proactively treat people with heart failure in their own homes and empower them toward greater self-care.